Sign up to save tools and stay up to date with the latest in AI
bg
bg
1

Eye On AI: Startups Should Heed ‘AI-Washing’ Warnings

Mar 21, 2024 - news.crunchbase.com
The U.S. Securities and Exchange Commission (SEC) has settled charges against two investment advisers, Delphia and Global Predictions, for allegedly making false statements about their use of AI. The firms agreed to pay a total of $400 million in civil penalties. This follows a warning from SEC Chair Gary Gensler about “AI washing,” or making false artificial intelligence-related claims related to their business. The U.S. attorney for the Northern District of California, Ismail Ramsey, also stated that he will be targeting tech startups that mislead investors about key information, including their use of AI.

In other news, the intersection of AI and healthcare is growing, with several healthcare startups securing significant funding. Zephyr AI closed a $111 million Series A, Carlsmed secured a $52.5 million Series C, and Hippocratic AI raised a $53 million Series A. Furthermore, Johnson & Johnson announced a collaboration with Nvidia to develop new AI applications for surgery.

Key takeaways:

  • The U.S. Securities and Exchange Commission (SEC) has settled charges against two investment advisers, Delphia and Global Predictions, for allegedly making false statements about their use of AI, resulting in a total of $400 million in civil penalties.
  • SEC Chair Gary Gensler has warned businesses about 'AI washing', which refers to making false artificial intelligence-related claims related to their business.
  • The U.S. attorney for the Northern District of California, Ismail Ramsey, has stated that he will be targeting tech startups that mislead investors about key information, including their use of AI, to try to defraud investors.
  • There has been a surge in the intersection of AI and healthcare, with several healthcare startups raising significant funding for their AI-enabled solutions, including Zephyr AI, Carlsmed, and Hippocratic AI.
View Full Article

Comments (0)

Be the first to comment!